Trials / Completed
CompletedNCT00581425
Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
Intron-A/Aldara Combination Therapy for BCC Excluding the Face and Scalp
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Imiquimod and Interferon alpha | Imiquimod first two weeks and last two weeks. Interferon middle five weeks. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2007-12-27
- Last updated
- 2013-01-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00581425. Inclusion in this directory is not an endorsement.